2017 CABA Investment & Entrepreneurship Symposium

September 8, 2017

The annual CABA Investment and Entrepreneurship Symposium is an influential event attracting prominen entrepreneurs, investors, biotech and pharma executives, academic and industry scientists, as well as professionals from the legal, finance, and healthcare fields. The topics of this year’s presentation and discussion will include venture capital investment, partnership & collaboration, entrepreneur experience both in US and China, etc. The symposium provide a great opportunity to network with hundreds of professionals including scientists, entrepreneurs, investors, et al in USA and China. Past symposiums were extremely well attended. We expect this year’s event will see around 200 professionals. The topics include venture capital investment, partnership & collaboration, university technology transfer, entrepreneur experience both in US and China, etc. The symposium provide a great opportunity to network with hundreds of professionals including scientists, entrepreneurs, investors, et al in USA and China. 


When: Saturday, September 30th.,2017 (8:30 AM – 5:30 PM)
Where: Conference Center at Waltham Woods, 860 Winter Street, Waltham, MA 02451

Admission 

CABA members: FREE; Non-members: $30. On-site membership registration available ($30 annual membership fee due, $15 for student).

Parking 

Free


Conference Organizing Committee Contact

Yibin Wei, PhD, MBA,

Email:  ben.wei@cabaweb.org

WeChat: ucb001


Registration >>

 

Program Book


Agenda

 

 

08:30am - 9:00am                     Registration / Continental Breakfast (Foyer)

 

09:00am - 9:05am                     Opening Remarks (Auditorium)

Ben Yibin Wei, Ph.D. MBA

Director, BD APAC, PerkinElmer

Chairman, Organizing Committee

 

09:05am - 9:15am                     Introduction of Chinese-American BioMedical Association (CABA)

Kevin Fang, Ph.D.

Senior Director, Sunovion

President, Chinese-American BioMedical Association (CABA)

 

09:15am - 3:30pm                     Private 1-on-1 Sessions between Investors and Startup Companies (Berkshire Room) 

 

09:15am - 10:35am        Session I: Entrepreneurship in Today’s Biotech Industry (Auditorium) 

                                                Moderator, Lan Cao, Ph.D.  CRISPR Therapeutics

 

09:15am - 9:35am          Rules of the Road – Biotechnology Entrepreneurship

David Lucchino, MBA, Co-founder, President and CEO, Frequency Therapeutics, Incoming Chairman, Board of Directors, Massachusetts Biotechnology Council

 

09:35am - 9:55am          Jacobio, a Novel Accelerator Model for Biotech Start-ups

Yinxiang Wang, Ph.D., Founder and Chairman, Beijing Jacobio Pharmaceuticals

 

09:55am - 10:15am        Building a Biotech Company in China — Personal Experience

                                    Yuelei Shen, Ph.D., Founder & CEO, Beijing Biocytogen Co. Ltd.

 

10:15am - 10:35am        Building a Medical Device Start-up Company in China

                                    Yu Li, MBA., Co-founder, Bowing Medical

 

10:35am - 10:50am                   Coffee Break (Foyer)

 

10:50am - 11:50am                   Session II: Investors’ Perspective on Biotech Investment and M&A (Auditorium) 

Moderator: Youxin Zhang, Ph.D. Navigant 

 

10:50am - 11:10am           Crossing Barriers in Cross-border Investment

Yining Zhao, Ph.D., Venture Partner, Lilly Asia Ventures

 

11:10am - 11:30am        Everest Medicines: Building a Partner of Choice in China

Sean Wuxiong Cao, Ph.D., Managing Director, C-Bridge Capital

President and Interim CEO at Everest Medicines

 

11:30am - 11:50am        Recent Acquisition Deals for Cancer Immunotherapy Companies

Han Ying, Ph.D., CSO, Sanpower Group; Global Strategic Consultant, Dendreon

 

12:00pm - 1:00pm                     Lunch Break (Dining Room) and Exhibitor Show (Foyer)

 

1:00pm - 2:20pm                      Session III: Emerging Technologies in the Biomedical Industry 

Introduction of Moderator, Bo Ying, Ph.D. PNA Innovations

Moderator: Jun Wang, Ph.D. VP of Discovery Biology, Shanghai Medicilon Inc.

 

1:00pm - 1:20pm           From Start-up to IPO

Jun Wang, Ph.D., VP of Discovery Biology, Shanghai Medicilon Inc.

 

1:20pm - 1:20pm           How a Protein Company Becomes a Great Partner

Mike Yiding Chen, CEO, Acrobiosystems

 

1:40pm - 2:00pm           Early Investment Opportunities for Biomedical Care in China

Feng Li, Founding Partner, FreeS Fund

 

2:00pm - 2:20pm           From Seed to Exit in 15 Months: the Delinia Story

Lijun Wu, Ph.D., Entrepreneur-In-Residence, Atlas Venture

 

2:20pm - 3:30pm                      Session IV: Panel Discussion  

All-things-Considered for Biomedical Entrepreneurship and Investment: Technology, Funding, and Legal Issues

Moderator: Jian Shao, MBA, Senior Director, BD & Investment, Simcere of America, Inc.

 

Jiawen Han, Head of BD, New England, Qilu Pharmaceutical

Chong Xu, Ph.D., Senior Associate, F-Prime Capital

Jing Li, Ph.D., Senior Vice President, Wuxi Biologics

Weimin Tang, Ph.D., Executive Director, Hengrui Therapeutics Inc.

Chen Chen, Ph.D. J.D., Cooley LLP

Geoffrey Spolyar, J.D., Cooley LLP

 

3:30pm - 3:50pm                      Coffee Break (Foyer)

 

3:50pm - 4:50pm                      Startup Pitch Competition

 

4:50pm - 5:30pm                      CABA High School Student Research Award & Startup Pitch Award 

Susan Qu, Ph.D. MBA, Sanofi Genzyme

Cindy Yang, MBA, Biogen

 

5:30pm - 5:35pm                      Closing Remark (Auditorium)

 

6:00pm - 7:30pm                      Cocktail Reception (Berkshire room. Ticket sold separately)